cholesteatoma of external ear: A cholesteatoma which involves invasion of the squamous tissue into a localized area of bony erosion of the ear canal. It may develop spontaneously or as a consequence of infection, trauma or surgery.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
246 |
4. Check minimum number of eventsNone |
246 |
5. Include endpointsNone |
246 |
6. Filter based on genotype QC (FinnGen only) |
246 |
Control definitions (FinnGen only)
- Control exclude
- H8_EXTERNAL
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H60
- Name in latin
- Cholesteatoma meatus acustici externi
Similar endpoints
↥List of similar endpoints to
Cholesteatoma of external ear
based on the number of shared cases.
Similar with more cases:
- Otitis externa
- Diseases of external ear
- Diseases of the ear and mastoid process
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2037 | 1011 | 1016 |
| Only index persons | 1930 | 964 | 966 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.03 |
| Only index persons | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 64.36 | 65.08 | 63.74 |
| Only index persons | 63.84 | 64.05 | 63.64 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 246 | 106 | 140 |
| Unadjusted period prevalence (%) | 0.05 | 0.04 | 0.06 |
| Median age at first event (years) | 65.10 | 62.72 | 66.90 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 222
- Matched controls
- 2220
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H60.4
ICD-10 Finland
Cholesteatoma of external ear
+∞
321.5
222
*
UDC00
NOMESCO Finland
Ear microscopy
24.5
61.0
90
60
H71
ICD-10 Finland
Cholesteatoma of middle ear
91.1
60.2
65
10
DC1AD
NOMESCO Finland
Temporalbone CT
465.5
40.5
39
*
H60.9
ICD-10 Finland
Otitis externa, unspecified
21.9
36.4
54
32
DBD20
NOMESCO Finland
Plastic repair of external auditory canal
404.0
35.0
34
*
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
39.7
25.0
31
9
Z01.1
ICD-10 Finland
Examination of ears and hearing
6.0
23.5
74
171
H60.3
ICD-10 Finland
Other infective otitis externa
36.8
23.1
29
9
DFF00
NOMESCO Finland
Pure tone audiometry
7.0
22.7
61
114
H60.8
ICD-10 Finland
Other otitis externa
35.3
22.1
28
9
H66.0
ICD-10 Finland
Acute suppurative otitis media
11.0
21.5
42
46
TDA90
NOMESCO Finland
Removal wax from ear
33.9
21.1
27
9
H61.8
ICD-10 Finland
Other specified disorders of external ear
85.3
21.1
23
*
H65.3
ICD-10 Finland
Chronic mucoid otitis media
46.7
20.9
25
6
H61.2
ICD-10 Finland
Impacted cerumen
10.8
18.5
36
39
H66.9
ICD-10 Finland
Otitis media, unspecified
10.1
15.6
31
35
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
11.3
15.0
28
28
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
57.2
14.0
16
*
DBB00
NOMESCO Finland
Excision of lesion of external auditory canal
80.2
13.8
15
*
DEA10
NOMESCO Finland
Attico-antrotomy
+∞
13.7
13
*
DCD00
NOMESCO Finland
Myringoplasty
26.1
12.7
17
7
DFF15
NOMESCO Finland
Speech audiometry
7.0
11.4
28
45
H65.2
ICD-10 Finland
Chronic serous otitis media
26.6
11.3
15
6
H70
ICPC
Otitis externa
12.9
11.1
19
16
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
11.4
11.0
20
19
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
19.0
10.9
16
9
H70.1
ICD-10 Finland
Chronic mastoiditis
115.2
10.5
11
*
H13
ICPC
Plugged feeling ear
3.2
10.5
64
252
H01
ICPC
Ear pain/earache
4.6
10.2
36
90
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
3.1
9.8
63
254
R5120
NOMESCO Finland
Preparation of an aid
8.0
9.2
20
27
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
38.4
9.1
11
*
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
+∞
8.4
8
*
H04
ICPC
Ear discharge
7.3
8.3
19
28
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
18.0
8.2
12
7
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
6.6
8.1
20
33
S18
ICPC
Laceration/cut
2.3
8.0
110
667
H92.0
ICD-10 Finland
Otalgia
6.4
7.9
20
34
H60
ICD-10 Finland
Otitis externa
7.9
7.8
17
23
DCD10
NOMESCO Finland
Tympanoplasty
46.6
7.8
9
*
DEB25
NOMESCO Finland
Attico-antro-mastoidectomy and tympanoplasty
46.6
7.8
9
*
38700
ICD-8 Finland
Other disease of ear and mastoid process, Cholesteatoma of ear
46.6
7.8
9
*
J01CA04
ATC
amoxicillin; systemic
2.6
7.7
181
1406
D23.2
ICD-10 Finland
Benign neoplasm: Skin of ear and external auricular canal
26.0
7.6
10
*
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
8.1
7.5
16
21
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
8.8
7.4
15
18
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
8.8
7.4
15
18
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
5.2
7.4
22
46
ZXA05
NOMESCO Finland
Left side
2.4
7.3
77
407
DBB02
NOMESCO Finland
Excision of a neoplasm from external auditory canal
+∞
7.3
7
*
DBD10
NOMESCO Finland
Reconstruction of external auditory canal
+∞
7.3
7
*
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
16.4
7.3
11
7
H72.2
ICD-10 Finland
Other marginal perforations of tympanic membrane
20.8
7.2
10
5
WX110
NOMESCO Finland
Local anesthesy
2.2
7.2
150
1078
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.5
7.1
64
309
H81
ICPC
Excessive ear wax
2.7
6.7
50
218
H68.1
ICD-10 Finland
Obstruction of Eustachian tube
18.7
6.3
9
5
H74.1
ICD-10 Finland
Adhesive middle ear disease
+∞
6.3
6
*
J01DB01
ATC
cefalexin; oral
2.3
6.1
183
1482
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.7
6.1
44
187
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
89
225
5.63
35.23
2.8
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
72
309
2.88
11.86
2.9
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
55
250
2.55
7.82
2.2
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
94
593
1.95
5.73
5.3
4.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
33
149
2.40
4.69
4.6
4.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
48
257
2.08
4.54
5.4
6.6
mmol/l
2.0
1.1
0.76
40
198
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
72
451
1.84
4.30
1.5
1.8
mg/l
1.1
1.5
0.70
59
361
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
222
1959
2.37
4.07
25.4
15.4
mg/l
26.9
24.7
0.43
190
1568
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
38
194
2.13
4.05
2.2
2.6
ug/l
3.8
6.3
1.29
33
173
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
125
931
1.70
4.03
5.6
4.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
92
634
1.72
3.93
2.2
2.0
u/l
215.6
220.2
0.02
84
592
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
186
1554
1.81
3.86
8.7
7.8
u/l
79.0
80.1
0.11
174
1456
(40768804) Tissue Pathology biopsy report
109
792
1.68
3.79
2.3
2.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
25
110
2.42
3.76
7.2
8.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
137
1070
1.63
3.50
3.1
2.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
127
975
1.63
3.47
5.1
3.7
estimate
0.0
0.0
0.00
26
189
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
43
244
1.92
3.44
9.3
8.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
144
1155
1.60
3.17
10.1
9.7
e9/l
4.4
4.2
0.66
132
1026
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
54
338
1.77
3.16
2.3
1.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
173
1458
1.63
3.03
5.8
4.1
mm/h
14.7
12.8
0.86
164
1335
(3019150) Specific gravity of Urine by Refractometry
64
426
1.68
3.00
5.8
4.2
kg/l
1.0
1.0
—
10
57
(3032080) INR in Blood by Coagulation assay
114
875
1.56
2.98
16.3
8.9
inr
1.2
1.2
0.16
33
245
(3002582) Erythrocytes [#/volume] in Urine
88
643
1.57
2.82
3.8
3.2
e6/l
24.5
158.5
0.76
71
507
(3021601) Nitrite [Presence] in Urine by Test strip
124
979
1.54
2.80
6.4
5.1
estimate
0.0
0.0
0.00
26
191
(3020564) Creatinine [Moles/volume] in Serum or Plasma
228
2093
2.22
2.80
26.6
18.4
umol/l
87.9
81.1
0.55
228
2093
(3009261) Glucose [Presence] in Urine by Test strip
125
993
1.53
2.72
5.1
3.7
estimate
0.0
0.0
0.00
23
179
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
101
768
1.53
2.68
5.7
3.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
65
449
1.61
2.61
3.2
2.6
e6/l
2.5
4.1
1.76
60
395
(3011397) Hemoglobin [Presence] in Urine by Test strip
64
442
1.61
2.57
4.4
3.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
128
1031
1.50
2.56
7.2
5.6
e9/l
1.9
1.9
0.07
116
920
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
58
393
1.62
2.51
5.1
3.4
ng/l
480.3
184.4
0.38
47
326
(3013826) Glucose [Moles/volume] in Serum or Plasma
148
1233
1.50
2.48
5.3
4.6
mmol/l
6.8
6.8
0.06
136
1148
(3013115) Eosinophils [#/volume] in Blood
128
1036
1.49
2.47
7.4
5.8
e9/l
0.2
0.2
1.22
117
919
(3001604) Monocytes [#/volume] in Blood
125
1008
1.49
2.45
6.8
5.6
e9/l
0.6
0.6
0.49
112
877
(3006315) Basophils [#/volume] in Blood
125
1011
1.48
2.40
7.2
5.6
e9/l
0.0
0.0
0.81
112
884
(3010813) Leukocytes [#/volume] in Blood
231
2153
2.20
2.35
34.1
22.8
e9/l
7.5
6.8
1.60
231
2099
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
126
1024
1.47
2.34
8.2
6.7
mmol/l
1.2
1.2
1.71
108
856
(3037467) Urinalysis macro (dipstick) panel - Urine
161
1376
1.49
2.30
5.7
4.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
44
285
1.66
2.27
38.3
22.1
inr
1.4
1.3
0.23
12
33
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
199
1782
1.61
2.26
5.1
4.4
mu/l
2.2
2.0
1.33
180
1617
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
54
2.49
2.24
1.3
1.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
9
5.64
2.22
1.6
2.1
%
14.5
13.6
—
5
9
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
42
2.69
2.21
1.2
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
37
232
1.70
2.15
2.4
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
37
232
1.70
2.15
2.6
1.7
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
49
2.52
2.14
1.2
1.5
—
—
—
0
0
(3024731) MCV [Entitic volume]
230
2152
2.06
2.12
34.1
22.7
fl
91.4
91.5
0.08
230
2126
(3035941) MCH [Entitic mass]
230
2152
2.06
2.12
34.1
22.6
pg
30.4
30.5
0.29
230
2126
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
8
25
3.27
2.11
1.1
1.5
nmol/l
0.5
0.5
—
8
20
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
224
2079
1.87
2.10
13.3
10.9
u/l
24.2
26.1
1.00
219
2018
(3026361) Erythrocytes [#/volume] in Blood
230
2153
2.05
2.10
34.3
22.7
e12/l
4.4
4.5
0.83
230
2098
(3000963) Hemoglobin [Mass/volume] in Blood
230
2153
2.05
2.10
34.4
22.9
g/l
132.5
135.4
2.09
230
2126
(40761511) CBC panel - Blood by Automated count
220
2034
1.77
2.05
23.3
14.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
216
1989
1.70
2.02
5.1
5.2
mmol/l
2.5
2.7
1.28
201
1835
(3018095) Leukocytes [#/volume] in Urine
95
750
1.43
1.97
4.2
3.6
e6/l
43.7
79.7
0.57
74
546
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
107
864
1.42
1.96
4.7
4.1
ng/l
29.0
41.9
1.06
82
635
(44790048)
8
27
3.03
1.95
1.1
1.6
—
—
—
0
0
(44790047)
8
27
3.03
1.95
1.1
1.6
—
—
—
0
0
(44806118)
8
27
3.03
1.95
1.1
1.6
—
—
—
0
0
(44790049)
8
27
3.03
1.95
1.1
1.6
—
—
—
0
0
(4010399)
27
159
1.78
1.95
1.4
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
210
1925
1.62
1.94
4.7
4.8
mmol/l
6.0
6.1
0.13
192
1773
(3007461) Platelets [#/volume] in Blood
229
2151
1.94
1.90
34.4
22.7
e9/l
242.8
242.7
0.01
229
2102
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
22
3.24
1.89
1.1
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
24
138
1.82
1.87
2.0
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
85
663
1.43
1.87
3.4
3.5
mmol/l
2.3
2.3
0.50
75
583
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
25
146
1.79
1.86
1.5
1.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
12
4.23
1.83
1.0
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
23
3.10
1.81
1.1
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
13
61
2.19
1.75
1.1
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
15
75
2.06
1.73
1.8
3.7
g/l
0.6
0.2
—
6
27
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
13
3.90
1.72
5.8
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
13
3.90
1.72
1.2
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
71
544
1.43
1.70
6.4
4.0
estimate
0.0
0.0
0.00
25
183
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
94
757
1.39
1.70
4.3
3.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
113
940
1.37
1.67
7.2
5.8
mmol/l
1.2
1.2
2.35
108
843
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
210
1944
1.55
1.63
4.8
4.7
mmol/l
4.5
4.5
0.40
195
1803
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
14
3.62
1.62
1.0
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
65
498
1.41
1.55
6.0
7.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
101
834
1.36
1.53
2.3
2.0
pmol/l
89.6
95.0
0.43
62
439
(4062490)
6
21
2.90
1.51
1.5
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
67
519
1.40
1.50
2.3
2.0
mg/l
2.7
3.2
1.09
58
453
(42870588) Differential panel, method unspecified - Blood
85
687
1.36
1.47
7.1
5.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
98
810
1.35
1.47
2.3
2.3
nmol/l
81.0
76.6
0.83
88
713
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
52
2.17
1.46
1.5
1.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
208
1933
1.49
1.46
4.7
4.6
mmol/l
1.4
1.4
0.21
192
1783
(36304419) Bacteria [Presence] in Urine
71
558
1.38
1.46
3.3
2.9
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
16
3.17
1.44
5.0
4.3
u/ml
10.3
116.6
—
5
16
(3005570) Glucose [Moles/volume] in Urine
6
22
2.77
1.44
1.7
2.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
58
441
1.41
1.44
6.6
4.9
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
112
947
1.34
1.43
8.1
5.8
%
8.4
8.8
0.78
106
897
(3002030) Lymphocytes/100 leukocytes in Blood
114
967
1.33
1.42
8.0
5.7
%
26.9
26.8
0.04
108
908
(3045424) Erythrocytes [Presence] in Urine
7
29
2.45
1.40
1.9
1.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
201
1861
1.44
1.39
18.8
14.7
ml/min/173m2
78.5
77.9
0.16
175
1546
(3006504) Eosinophils/100 leukocytes in Blood
111
943
1.32
1.36
7.8
5.6
%
3.4
2.8
1.72
105
886
(3005322) IgE [Units/volume] in Serum or Plasma
17
98
1.79
1.35
1.5
1.2
u/ml
1043.9
187.8
0.80
17
86
(3018010) Neutrophils/100 leukocytes in Blood
112
955
1.32
1.33
7.8
5.5
%
58.8
58.0
0.25
107
907
(3030467) Casts [#/volume] in Urine by Automated count
73
585
1.35
1.32
3.5
3.0
e6/l
0.3
0.4
0.30
56
447
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
84
1.84
1.30
2.2
3.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
62
1.98
1.30
1.1
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
160
1439
1.32
1.26
4.6
3.7
pmol/l
14.5
14.9
1.04
144
1286
(3020891) Body temperature
15
85
1.81
1.26
4.5
4.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
87
721
1.32
1.25
4.9
4.6
%
21.4
21.0
0.10
47
356
(3026493) Urate [Moles/volume] in Serum or Plasma
66
526
1.35
1.23
3.0
3.0
umol/l
354.1
7383.7
2.39
55
452
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
38
2.14
1.19
1.6
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
19
118
1.66
1.19
1.3
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
79
650
1.32
1.18
2.8
2.4
—
—
—
0
0
(3044889) 12 lead EKG panel
157
1417
1.30
1.16
4.3
4.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
20
2.53
1.15
1.0
1.1
u/ml
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
20
2.53
1.15
1.4
2.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
83
693
1.30
1.11
3.1
3.3
ng/l
1351.2
1577.3
0.25
76
591
(3026008) Bacteria identified in Urine by Culture
73
599
1.31
1.11
4.0
3.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
33
2.15
1.06
1.0
1.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
106
920
1.27
1.04
8.0
5.5
%
0.8
0.6
1.22
99
864
(4306422)
5
22
2.30
1.04
1.0
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
22
2.30
1.04
1.2
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
14
83
1.73
1.04
2.0
1.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
17
107
1.63
1.02
1.4
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
25
173
1.50
1.02
5.2
3.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
9
49
1.87
0.99
3.4
2.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
85
1.69
0.96
1.6
2.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
9
51
1.79
0.95
2.0
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
13
78
1.70
0.93
1.5
1.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
197
1856
1.31
0.91
6.7
6.3
mmol/mol
41.0
40.6
0.22
179
1732
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
141
1278
1.24
0.91
3.4
3.1
u/l
56.0
51.7
0.26
127
1196
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
21
144
1.50
0.91
3.2
3.6
mmol/l
1.3
1.8
0.37
16
110
(3000991) Gas panel - Venous blood
24
170
1.46
0.89
6.4
7.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
43
1.89
0.88
1.3
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
17
113
1.54
0.84
3.1
3.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
32
1.90
0.82
1.0
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
9
148
0.59
0.82
2.1
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
21
148
1.46
0.81
4.1
2.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
18
124
1.49
0.77
1.4
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
30
228
1.36
0.77
1.4
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
160
0.61
0.76
1.5
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
185
1743
1.25
0.76
24.8
16.1
%
39.2
39.8
0.36
103
1209
(3026782) Osmolality of Urine
51
420
1.27
0.76
3.3
2.9
mosm/kgh2o
518.0
565.4
0.91
45
358
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
102
907
1.21
0.75
5.2
5.1
ug/l
1.8
2.9
1.25
93
823
(40768800) Prostate Pathology biopsy report
9
54
1.69
0.75
1.1
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
74
637
1.23
0.75
5.1
4.0
ph
7.4
7.4
0.09
16
125
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
58
486
1.25
0.75
2.6
2.3
—
—
—
0
0
(4034850)
9
55
1.66
0.74
10.3
11.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
110
0.53
0.74
1.3
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
31
239
1.34
0.74
1.2
1.3
titre
445.0
495.8
—
8
48
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
31
239
1.34
0.74
3.9
4.6
ug/l
3.7
61.8
1.06
26
204
(3004616) Nuclear Ab [Presence] in Serum
5
25
2.02
0.73
1.2
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
42
1.69
0.69
2.3
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
27
1.87
0.69
1.8
2.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
7
43
1.65
0.67
1.0
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
27
207
1.34
0.67
4.0
3.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
35
279
1.30
0.67
1.3
1.3
u/ml
1.5
14.2
1.61
15
103
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
28
1.80
0.66
1.0
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
28
1.80
0.66
1.0
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
28
1.80
0.66
1.0
1.9
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
10
62
1.64
0.66
1.2
1.7
—
0.1
—
0
15
(3019309) Folate [Moles/volume] in Red Blood Cells
50
419
1.24
0.65
1.7
1.8
nmol/l
1188.6
1217.7
0.08
36
317
(3012441) Differential panel - Pleural fluid
5
30
1.68
0.62
2.0
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
61
700
0.83
0.60
3.1
3.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
53
1.53
0.59
1.7
1.9
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
26
203
1.31
0.58
6.4
3.7
mmol/l
1.4
2.0
0.30
18
154
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
27
212
1.31
0.58
1.7
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
33
267
1.27
0.58
1.6
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
22
169
1.33
0.55
5.5
3.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
60
522
1.20
0.55
1.6
1.6
nmol/l
19.3
21.0
0.30
53
446
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
38
1.59
0.54
1.2
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
15
108
1.41
0.54
1.4
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
9
64
1.42
0.52
1.8
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
74
660
1.17
0.51
3.6
4.0
mg/mmol
8.1
9.4
0.11
50
425
(3009508) Creatinine [Moles/volume] in Urine
71
632
1.17
0.50
3.1
3.1
mmol/l
6.9
7.5
0.57
62
525
(3001122) Ferritin [Mass/volume] in Serum or Plasma
91
827
1.16
0.50
3.0
2.6
ug/l
125.4
149.1
0.47
82
759
(3012516) Albumin [Mass/volume] in Urine
69
614
1.17
0.49
3.2
3.2
mg/l
719.1
263.7
0.29
43
403
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
7
46
1.54
0.48
1.0
1.1
nmol/l
1.1
0.9
—
7
38
(3014051) Protein [Presence] in Urine by Test strip
7
46
1.54
0.48
2.1
2.1
—
—
—
0
0
(3000492) Spirometry study
23
182
1.29
0.48
1.6
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
195
1877
1.19
0.48
4.3
4.2
mmol/l
1.3
1.3
0.56
178
1724
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
47
1.50
0.48
1.0
1.6
—
—
—
0
0
(3012544) pH of Venous blood
26
212
1.25
0.44
6.8
3.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
58
514
1.17
0.43
3.6
3.0
ug/l
0.7
0.7
0.17
44
343
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
21
167
1.28
0.43
3.1
3.0
ml/min/173m2
80.0
61.0
—
9
71
(40768806) Pleura Pathology biopsy report
5
32
1.57
0.42
2.6
1.7
—
—
—
0
0
(3013512) EKG study
68
612
1.15
0.42
4.5
4.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
34
1.48
0.40
1.6
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
137
0.72
0.40
1.8
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
35
1.44
0.39
2.0
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
95
880
1.13
0.38
10.9
10.2
e9/l
0.0
0.0
0.30
80
730
(3004588) Protein electrophoresis panel - Serum or Plasma
19
152
1.27
0.38
3.2
2.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
35
301
1.19
0.37
1.4
1.2
iu/ml
14.8
42.0
2.94
13
99
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
37
1.36
0.37
1.0
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
23
190
1.23
0.36
1.6
1.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
16
126
1.29
0.36
1.3
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
80
0.62
0.36
1.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
43
1.41
0.35
1.7
1.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
44
1.37
0.34
1.0
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
45
1.34
0.34
2.3
2.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
45
503
0.87
0.33
1.3
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
42
373
1.15
0.32
1.8
1.4
g/l
3.7
2.7
0.28
18
235
(3021447) Carbon dioxide [Partial pressure] in Venous blood
24
203
1.20
0.31
6.8
3.7
kpa
6.0
5.7
1.29
24
195
(3041096) Erythrocytes [Presence] in Urine by Automated
61
557
1.13
0.31
5.6
3.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
7
53
1.33
0.31
3.4
3.9
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
111
1.28
0.30
2.4
2.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
7
55
1.28
0.30
1.0
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
57
522
1.12
0.28
1.8
1.7
mmol/l
2.2
1.4
0.66
48
430
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
39
349
1.14
0.27
3.4
2.7
e6/l
0.8
1.1
0.43
21
205
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
12
95
1.28
0.27
4.5
3.2
mmol/l
23.4
24.1
—
7
87
(1761482) Bacteria [#/volume] in Urine by Culture
5
72
0.69
0.26
7.0
5.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
51
466
1.12
0.26
1.7
1.9
pmol/l
340000425.3
433.3
0.78
40
386
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
9
74
1.22
0.25
3.4
3.2
—
1.5
—
0
8
(3034860) Kappa light chains.free [Mass/volume] in Serum
9
75
1.21
0.25
3.6
3.3
mg/l
49.4
159.8
—
9
57
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
9
75
1.21
0.25
3.6
3.4
mg/l
79.7
32.7
—
9
58
(40768797) Stomach Pathology biopsy report
31
275
1.15
0.24
1.4
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
20
173
1.17
0.21
4.7
3.0
kpa
4.0
4.4
0.72
20
164
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
42
1.19
0.21
1.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
0
11
0.00
0.21
0.0
1.3
—
1.0
—
0
6
(3037556) Urate [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.5
—
6.3
—
0
7
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
3.6
—
98.3
—
0
12
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
89
1.25
0.21
4.7
2.0
g/l
5.9
7.5
—
5
68
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
89
1.25
0.21
4.7
2.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
1.0
—
0
13
(3016018) Differential panel - Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
48
1.26
0.20
1.2
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(4035726)
17
195
0.86
0.18
2.0
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
24
214
1.13
0.18
1.8
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
61
1.15
0.17
1.7
1.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
10
82
1.23
0.17
1.3
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
63
1.11
0.17
1.6
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
33
302
1.11
0.17
2.9
2.4
%
21.2
21.9
0.09
22
265
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
43
400
1.09
0.16
1.2
1.2
u/ml
0.9
1.2
—
7
125
(1002224) Polysomnography panel
6
79
0.75
0.15
1.2
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
8
98
0.81
0.14
4.1
3.8
u/ml
86.4
2116.7
—
8
81
(3049717) Cytology report of Urine Cyto stain
11
94
1.18
0.13
3.0
2.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
9
110
0.81
0.13
1.0
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
123
1.15
0.13
2.3
1.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
10
116
0.86
0.12
1.2
1.3
—
35.8
—
0
10
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
13
114
1.15
0.12
3.5
2.7
%
1.3
1.3
0.00
13
114
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
21
193
1.10
0.10
1.6
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
47
1.07
0.09
1.0
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
47
1.07
0.09
1.2
1.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
6
56
1.07
0.08
1.5
1.8
mg/l
15.5
13.6
—
6
51
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
29
274
1.07
0.08
1.9
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
74
0.81
0.07
1.2
1.8
—
—
—
0
0
(3002256) Pathology report gross observation
27
256
1.06
0.06
1.4
1.3
—
—
—
0
0
(3019225) pH of Specimen
21
197
1.07
0.06
3.0
4.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
18
169
1.07
0.05
6.9
3.5
%
0.0
0.2
—
7
53
(3023520) Reticulocytes [#/volume] in Blood
22
209
1.06
0.04
1.7
2.7
e9/l
61.5
69.5
0.63
15
159
(3027945) Reticulocytes/100 erythrocytes in Blood
27
280
0.96
0.03
2.2
2.6
%
1.7
1.8
0.27
20
253
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
27
262
1.03
0.02
4.3
4.7
%
31.6
31.3
0.05
16
184
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
101
0.99
0.00
1.2
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
121
0.99
0.00
1.2
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
18
181
0.99
0.00
6.9
3.5
%
0.3
0.9
—
7
59
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
33
326
1.01
0.00
3.9
2.9
e6/l
1.3
1.8
0.42
16
187
(3052851) Hemolysis interference index of Serum or Plasma
6
59
1.02
0.00
4.7
3.8
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
118.4
—
0
5
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
5
0.00
0.00
0.0
11.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
11.2
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
0
8
0.00
0.00
0.0
2.0
—
65.5
—
0
8
(3014891) Appearance of Pleural fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
19.4
—
0
7
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
9.2
—
0
6
(4094501)
5
53
0.94
0.00
1.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
7
0.00
0.00
0.0
7.6
—
25.5
—
0
7
(3010375) cycloSPORINE [Mass/volume] in Blood
0
9
0.00
0.00
0.0
31.1
—
75.8
—
0
9
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
11.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
12
120
1.00
0.00
5.5
4.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
9
0.00
0.00
0.0
1.0
—
8.5
—
0
9
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4211845)
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
145.8
—
0
6
(42529406) Shigella sp [Presence] in Stool by Culture
5
59
0.84
0.00
1.0
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
59
0.84
0.00
1.0
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
0
5
0.00
0.00
0.0
1.2
—
15.0
—
0
5
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
59
0.84
0.00
1.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H8_EXT_CHOL and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_EXT_CHOL | 1.283 [1.02, 1.62] | 0.035 |
| Birth year | 0.998 [0.99, 1.01] | 0.613 |
During the follow-up period (1.1.1998 — 31.12.2019), 222 out of 870 females with H8_EXT_CHOL died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_EXT_CHOL | 1.268 [1.01, 1.6] | 0.043 |
| Birth year | 0.99 [0.98, 1.0] | 0.031 |
During the follow-up period (1.1.1998 — 31.12.2019), 225 out of 883 males with H8_EXT_CHOL died.
Mortality risk
Mortality risk for people of age
years, who have H8_EXT_CHOL.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.122% | 0.26% |
| 5 | 0.774% | 1.499% |
| 10 | 2.0% | 3.783% |
| 15 | 3.865% | 7.259% |
| 20 | 6.95% | 12.422% |
Relationships between endpoints
↥Index endpoint: H8_EXT_CHOL – Cholesteatoma of external ear
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data